These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23463744)

  • 21. Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain.
    Minkowitz H; Bull J; Brownlow RC; Parikh N; Rauck R
    Support Care Cancer; 2016 Jun; 24(6):2669-75. PubMed ID: 26780504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transmucosal fentanyl and breakthrough pain: The other side of the coin].
    Henche Ruiz AI
    Rev Esp Geriatr Gerontol; 2020; 55(1):56-57. PubMed ID: 31307779
    [No Abstract]   [Full Text] [Related]  

  • 23. Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group.
    Mercadante S; Marchetti P; Cuomo A; Mammucari M; Caraceni A;
    Support Care Cancer; 2016 Feb; 24(2):961-968. PubMed ID: 26438145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial design for breakthrough pain: is it ethical to have a placebo in a trial?
    Davis MP; Bruera E
    Clin Ther; 2014 May; 36(5):814-5. PubMed ID: 24726089
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness analysis of transnasal fentanyl citrate for the treatment of breakthrough cancer pain.
    Ruggeri M; Turriziani A; Oradei M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):459-64. PubMed ID: 24702061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.
    Alberts DS; Smith CC; Parikh N; Rauck RL
    Pain Manag; 2016 Oct; 6(5):427-34. PubMed ID: 27020837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fentanyl Buccal Soluble Film: A Review in Breakthrough Cancer Pain.
    Garnock-Jones KP
    Clin Drug Investig; 2016 May; 36(5):413-9. PubMed ID: 27007271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain.
    Mercadante S; Vellucci R; Cuomo A; Adile C; Cortegiani A; Valle A; Villari P; Casuccio A
    Support Care Cancer; 2015 May; 23(5):1349-54. PubMed ID: 25351457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trial design for breakthrough pain: is it ethical to have a placebo in a trial? Author reply.
    Trinquet F
    Clin Ther; 2014 May; 36(5):816. PubMed ID: 24726087
    [No Abstract]   [Full Text] [Related]  

  • 31. Fentanyl buccal tablet for the treatment of cancer-related breakthrough pain.
    Mercadante S
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):9-13. PubMed ID: 25359295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How practical are transmucosal fentanyl products for breakthrough cancer pain? Novel use of placebo formulations to survey user opinion.
    England R; Maddocks M; Manderson C; Zadora-Chrzastowska S; Wilcock A
    BMJ Support Palliat Care; 2011 Dec; 1(3):349-51. PubMed ID: 24653483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain.
    Bulloch MN; Hutchison AM
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):9-22. PubMed ID: 23272789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.
    Núñez-Olarte JM; Alvarez-Jiménez P
    J Pain Symptom Manage; 2011 Dec; 42(6):e6-8. PubMed ID: 22048003
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimal management of breakthrough cancer pain (BCP).
    Escobar Y; Mañas A; Juliá J; Gálvez R; Zaragozá F; Margarit C; López R; Casas A; Antón A; Cruz JJ
    Clin Transl Oncol; 2013 Jul; 15(7):526-34. PubMed ID: 23263914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facilitation of accurate and effective radiation therapy using fentanyl pectin nasal spray (FPNS) to reduce incidental breakthrough pain due to procedure positioning.
    Prieto I; Pardo J; Luna J; Marin JP; Olivera J; Garcia AJ; Perez AM
    Scand J Pain; 2016 Apr; 11():52-58. PubMed ID: 28850470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain.
    Taylor D; Radbruch L; Revnic J; Torres LM; Ellershaw JE; Perelman M
    J Pain Symptom Manage; 2014 Jun; 47(6):1001-7. PubMed ID: 24128821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study.
    Mercadante S; Adile C; Cuomo A; Aielli F; Cortegiani A; Casuccio A; Porzio G
    J Pain Symptom Manage; 2015 Nov; 50(5):579-86. PubMed ID: 26303188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of nasal fentanyl for cancer pain: A pharmacoepidemiological study.
    Fredheim OM; Mahic M; Skurtveit S; Borchgrevink PC
    Palliat Med; 2015 Jul; 29(7):661-6. PubMed ID: 25762579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fentanyl: fast and furious?].
    Meissner W; Sabatowski R
    Anaesthesist; 2013 Jun; 62(6):429-30. PubMed ID: 23748418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.